Vogelmeier, Claus F.
Jones, Paul W.
Kerwin, Edward M.
Boucot, Isabelle H.
Maltais, François
Tombs, Lee
Compton, Chris
Lipson, David A.
Bjermer, Leif H.
Funding for this research was provided by:
GSK (201749 [NCT03034915])
Article History
Received: 13 May 2021
Accepted: 8 October 2021
First Online: 28 October 2021
Change Date: 18 March 2022
Change Type: Update
Change Details: The open access funding note has been updated.
Declarations
:
: This study was performed according to the Declaration of Helsinki and received appropriate ethical approval (Additional file InternalRef removed). All patients provided written informed consent at either the pre-screening or screening visit.
: Not applicable.
: CFV has received grants from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Grifols, Mundipharma, Novartis, and the German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), and has received personal fees from AstraZeneca, Boehringer Ingelheim, Berlin Chemie/Menarini, Chiesi, CSL Behring, GSK, Grifols, MedUpdate, Novartis and Teva. EMK has served on advisory boards, speaker panels or received travel reimbursement for Amphastar, AstraZeneca, Boehringer Ingelheim, Connect Biopharma, GSK, Mylan, Novartis, Pearl, Sunovion, Teva and Theravance, and has received consulting fees from Cipla and GSK. IHB, DAL, CC and PWJ are employees of GSK and hold stock and shares in GSK. FM has received research grants for participating in multicentre trials for AstraZeneca, Boehringer Ingelheim, GSK, Sanofi and Novartis, and has received unrestricted research grants and personal fees from Boehringer Ingelheim, Grifols and Novartis. LT is a contingent worker on assignment at GSK. LHB has received honoraria for giving a lecture or attending an advisory board for Airsonett, ALK-Abelló, AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Meda, Novartis and Teva. DISKUS and ELLIPTA are owned by/licensed to the GSK group of companies.